Multiple aberrant pathways in HCC have been characterized such as the Ras-Raf-MAPK, PI3K-AKT-mTOR, Wnt-β-catenin, and JAK-STAT pathways [7–10]. The gene discussed is MTOR; the disease is hepatocellular carcinoma.